Barbara A. Belli
Washington University in St. Louis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Barbara A. Belli.
Journal of Virology | 2000
Jason P. Gardner; Ilya Frolov; Silvia Perri; Yaying Ji; Mary Lee MacKichan; Jan zur Megede; Minchao Chen; Barbara A. Belli; David A. Driver; Scott Sherrill; Catherine Greer; Gillis Otten; Susan W. Barnett; Margaret A. Liu; Thomas W. Dubensky; John M. Polo
ABSTRACT The ability to target antigen-presenting cells with vectors encoding desired antigens holds the promise of potent prophylactic and therapeutic vaccines for infectious diseases and cancer. Toward this goal, we derived variants of the prototype alphavirus, Sindbis virus (SIN), with differential abilities to infect human dendritic cells. Cloning and sequencing of the SIN variant genomes revealed that the genetic determinant for human dendritic cell (DC) tropism mapped to a single amino acid substitution at residue 160 of the envelope glycoprotein E2. Packaging of SIN replicon vectors with the E2 glycoprotein from a DC-tropic variant conferred a similar ability to efficiently infect immature human DC, whereupon those DC were observed to undergo rapid activation and maturation. The SIN replicon particles infected skin-resident mouse DC in vivo, which subsequently migrated to the draining lymph nodes and upregulated cell surface expression of major histocompatibility complex and costimulatory molecules. Furthermore, SIN replicon particles encoding human immunodeficiency virus type 1 p55Gag elicited robust Gag-specific T-cell responses in vitro and in vivo, demonstrating that infected DC maintained their ability to process and present replicon-encoded antigen. Interestingly, human and mouse DC were differentially infected by selected SIN variants, suggesting differences in receptor expression between human and murine DC. Taken together, these data illustrate the tremendous potential of using a directed approach in generating alphavirus vaccine vectors that target and activate antigen-presenting cells, resulting in robust antigen-specific immune responses.
Journal of Virology | 2000
Silvia Perri; David A. Driver; Jason P. Gardner; Scott Sherrill; Barbara A. Belli; Thomas W. Dubensky; John M. Polo
ABSTRACT Alphavirus replicon vectors are well suited for applications where transient, high-level expression of a heterologous gene is required. Replicon vector expression in cells leads to inhibition of host macromolecular synthesis, culminating in eventual cell death by an apoptotic mechanism. For many applications, including gene expression studies in cultured cells, a longer duration of transgene expression without resulting cytopathic effects is useful. Recently, noncytopathic Sindbis virus (SIN) variants were isolated in BHK cells, and the mutations responsible were mapped to the protease domain of nonstructural protein 2 (nsP2). We report here the isolation of additional variants of both SIN and Semliki Forest virus (SFV) replicons encoding the neomycin resistance gene that can establish persistent replication in BHK cells. The SIN and SFV variant replicons resulted from previously undescribed mutations within one of three discrete regions of the nsP2 gene. Differences among the panel of variants were observed in processing of the nonstructural polyprotein and in the ratios of subgenomic to genomic RNAs. Importantly, high-level expression of a heterologous gene was retained with most replicons. Finally, in contrast to previous studies, efficient packaging was obtained with several of the variant replicons. This work expands the utility of noncytopathic replicons and the understanding of how alphavirus replicons establish persistent replication in cultured cells.
Journal of Virology | 1996
Thomas W. Dubensky; David A. Driver; John M. Polo; Barbara A. Belli; Emi M. Latham; Carlos E. Ibanez; Sunil Chada; Duane Brumm; Theresa A. Banks; Steven J. Mento; Douglas J. Jolly; Stephen M. W. Chang
Journal of Virology | 1998
Mangala J. Hariharan; David A. Driver; Kay Townsend; Duane Brumm; John M. Polo; Barbara A. Belli; Donald J. Catton; David Chi-Tang Hsu; Denise Mittelstaedt; James E. McCormack; Linda Karavodin; Thomas W. Dubensky; Stephen M. W. Chang; Theresa Banks
Proceedings of the National Academy of Sciences of the United States of America | 1999
John M. Polo; Barbara A. Belli; David A. Driver; Ilya Frolov; Scott Sherrill; Mangala J. Hariharan; Kay Townsend; Silvia Perri; Steven J. Mento; Douglas J. Jolly; Stephen M. W. Chang; Sondra Schlesinger; Thomas W. Dubensky
Archive | 1998
Thomas W. Dubensky; John M. Polo; Barbara A. Belli; Sondra Schlesinger; Sergey A. Dryga; Ilya Frolov
Archive | 1997
Thomas W. Dubensky; John M. Polo; Barbara A. Belli; Sondra Schlesinger; Sergey A. Dryga; Ilya Frolov
Annals of the New York Academy of Sciences | 1995
David A. Driver; Emi M. Latham; John M. Polo; Barbara A. Belli; Theresa A. Banks; Sunil Chada; Duane Brumm; Stephen M. W. Chang; Steven J. Mento; Douglas J. Jolly; Thomas W. Dubensky
Archive | 2000
Barbara A. Belli; Thomas W. Piedmont Dubensky; Timothy Moraga Fong; Silvia Perri; John Polo
Archive | 2000
Barbara A. Belli; Thomas W. Piedmont Dubensky; Timothy Moraga Fong; Silvia Perri; John Polo